Brief: Genscript Biotech Agrees To Issue And Sell 320 Million Series C Preferred Shares
17/01/2023 14:45
Jan 17 (Reuters) - Genscript Biotech Corp 1548.HK :
* AGREED TO ISSUE AND SELL 320 MILLION SERIES C PREFERRED
SHARES
FOR $224.0 MILLION
Source text for Eikon: ID:
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale